The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4basebio Plc Regulatory News (4BB)

Share Price Information for 4basebio Plc (4BB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,080.00
Bid: 1,060.00
Ask: 1,100.00
Change: 0.00 (0.00%)
Spread: 40.00 (3.774%)
Open: 1,080.00
High: 1,080.00
Low: 1,080.00
Prev. Close: 1,080.00
4BB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

6 Feb 2024 07:01

4basebio Plc - Holding(s) in Company

4basebio Plc - Holding(s) in Company

PR Newswire

LONDON, United Kingdom, February 06

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BMCLYF79

Issuer Name

4BASEBIO PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An event changing the breakdown of voting rights

3. Details of person subject to the notification obligation

Name

2invest AG

City of registered office (if applicable)

Heidelberg

Country of registered office (if applicable)

Germany

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached

01-Feb-2024

6. Date on which Issuer notified

05-Feb-2024

7. Total positions of person(s) subject to the notification obligation

. % of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached 28.643189 0.000000 28.643189 3665242
Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible) Number of direct voting rights (DTR5.1) Number of indirect voting rights (DTR5.2.1) % of direct voting rights (DTR5.1) % of indirect voting rights (DTR5.2.1)
GB00BMCLYF79 3665242 28.643189
Sub Total 8.A 3665242 28.643189%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument Expiration date Exercise/conversion period Number of voting rights that may be acquired if the instrument is exercised/converted % of voting rights
Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument Expiration date Exercise/conversion period Physical or cash settlement Number of voting rights % of voting rights
Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person Name of controlled undertaking % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold
Wilhelm K.T. Zours
Wilhelm K.T. Zours DELPHI Unternehmensberatung Aktiengesellschaft 4.989259 4.989259%
Wilhelm K.T. Zours Deutsche Balaton Aktiengesellschaft 7.415955 7.415955%
Wilhelm K.T. Zours SPARTA AG 10.563426 10.563426%
Wilhelm K.T. Zours 2invest AG 28.643189 28.643189%

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion

13. Place Of Completion

Heidelberg, Germany



12
Date   Source Headline
10th Apr 20247:00 amPRN4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program
21st Mar 20247:00 amPRN4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine
1st Mar 20247:00 amPRN4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence
6th Feb 20247:01 amPRNHolding(s) in Company
6th Feb 20247:01 amPRNHolding(s) in Company
6th Feb 20247:01 amPRNHolding(s) in Company
6th Feb 20247:01 amPRNHolding(s) in Company
6th Feb 20247:00 amPRNExercise of Options
5th Feb 20247:01 amPRNHolding(s) in Company
5th Feb 20247:01 amPRNHolding(s) in Company
5th Feb 20247:01 amPRNHolding(s) in Company
5th Feb 20247:00 amPRNDirectors' Dealings
2nd Feb 20247:00 amPRNLong-Term Incentive Plan and Exercise of Options
21st Sep 20237:00 amPRNHalf-year Report
1st Aug 20237:00 amPRNGrant received from the Bill and Melinda Gates Foundation
27th Sep 20229:05 amRNSSecond Price Monitoring Extn
27th Sep 20229:00 amRNSPrice Monitoring Extension
6th May 20222:00 pmRNSPrice Monitoring Extension
23rd Mar 20227:00 amPRNRapidly Produced Customisable Synthetic DNA
15th Mar 20224:41 pmRNSSecond Price Monitoring Extn
15th Mar 20224:35 pmRNSPrice Monitoring Extension
15th Mar 20222:05 pmRNSSecond Price Monitoring Extn
15th Mar 20222:01 pmRNSPrice Monitoring Extension
15th Mar 202211:00 amRNSPrice Monitoring Extension
15th Mar 20229:00 amRNSPrice Monitoring Extension
8th Mar 20229:00 amRNSPrice Monitoring Extension
15th Feb 20227:00 amPRNDNA manufacturing update
18th Jan 20227:00 amPRNStrategic Research Collaboration
20th Dec 202112:49 pmPRNDirector/PDMR Shareholding
13th Dec 20213:55 pmPRNDirector/PDMR Shareholding
23rd Nov 20217:00 amPRNJoint Development Agreement with Leucid Bio
30th Sep 20217:00 amPRNHalf-year Report
28th Sep 20217:00 amPRNDevelopment of GMP Manufacturing Capacity
4th Aug 20214:40 pmRNSSecond Price Monitoring Extn
4th Aug 20214:35 pmRNSPrice Monitoring Extension
23rd Jul 20213:39 pmPRNFurther re Conversion to UK PLC
21st Jul 20217:00 amPRNConversion to UK PLC
1st Jul 20214:09 pmPRNDirector/PDMR Shareholding
30th Jun 202112:50 pmPRNResult of AGM
22nd Jun 20217:00 amPRNApplication filed for protected linearised synthetic DNA
18th Jun 20217:00 amPRNAnnual General Meeting 2021
4th Jun 20217:00 amPRNNotice of AGM and Posting of Accounts
3rd Jun 20217:00 amPRNFinal Results
27th Apr 20217:00 amPRNEvaluation licence for muscular dystrophy vector
26th Feb 20217:00 amPRNDirector/PDMR Shareholding
25th Feb 20219:05 amRNSSecond Price Monitoring Extn
25th Feb 20219:00 amRNSPrice Monitoring Extension
22nd Feb 202111:00 amRNSPrice Monitoring Extension
22nd Feb 20219:31 amPRNHolding(s) in Company
19th Feb 20215:35 pmPRNHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.